Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $53.92 ($21,568)
  2. 4 Open-market sale SVP & CFO sold 7,500 shares at $55.79 ($418,425)
  3. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $56.24 ($14,060)
  4. 4 Planned sale SVP, CHIEF HR OFFICER sold 1,000 shares at $60.00 ($60,000)
  5. 4 Open-market sale PRESIDENT & CEO sold 33,481 shares at an average $57.99 ($1,941,442)
  6. 4 Shares withheld for taxes SVP, HEAD - ESTABLISHED BRANDS gave up 867 shares (to pay taxes)
  7. 4 Open-market sale HEAD OF RARE DISEASE sold 6,500 shares at $57.70 ($375,050)
  8. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $61.36 ($15,340)
  9. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $57.19 ($14,298)
  10. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $56.82 ($14,205)
  11. 4 Shares withheld for taxes SVP, CHIEF HR OFFICER gave up 1,486 shares (to pay taxes)
  12. 4 Shares withheld for taxes PRESIDENT & CEO gave up 3,646 shares (to pay taxes)
  13. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $59.62 ($14,905)
  14. 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 2,743 shares at $62.00 ($170,066)
  15. 4 Shares withheld for taxes SR. VP, GENERAL COUNSEL & SEC. gave up 1,743 shares (to pay taxes)
  16. 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 47,257 shares at an average $63.73 ($3,011,592)
  17. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $64.91 ($16,228)
  18. 4 Planned sale SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $63.44 ($1,268,800)
  19. 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 20,000 shares at $58.90 ($1,178,000)
  20. 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 30,000 shares at an average $60.59 ($1,817,663)

Page 8 of 42 · 834 filings